Approximately three quarters of acute HCV infections evolve to a chronic state, while 34 one quarter are spontaneously cleared. Genetic predispositions strongly contribute to the 35 development of chronicity. We have conducted a genome-wide association study to 36 identify genomic variants underlying HCV spontaneous clearance using Immunochip in 37
approximately three quarters of acute HCV infections evolve to a chronic state, but one 48 quarter are spontaneously cleared 3 . As such, it is likely that genetic predispositions, 49 especially at loci that regulate the innate and/or adaptive immune response, strongly 50 contribute to the development of chronicity. A prior genome wide association study 51 (GWAS) conducted by our consortium demonstrated striking associations of spontaneous 52 resolution of HCV with polymorphisms near the IFN-L3 locus (IL28B) and in the HLA 53 class II locus (Duggal et al. 4 ). 54
The associations identified in Duggal et al. span large genomic regions, specifically 55 55,000 base pairs for the Il28B locus and > 1 mega base pairs for the HLA class II locus. 56
Recently advances in genomic technologies allowed a more precise characterization of 57 genetic associations and facilitated resolving these associations to much smaller genomic 58 regions. Firstly, Immunochip 5 , a customized array platform with deeper coverage of loci 59 enriched in autoimmune diseases, provides coverage of additional genomic variants for 60 an opportunity to explore with greater precision the contribution of these loci to the 61 clearance of viral infection. Secondly, additional coverage of the MHC region can be 62 gained using an imputation algorithm that takes into account the long range linkage-63 disequilibrium in MHC, and a large customized reference panel with improved coverage 64 of the MHC region 6 . Thirdly, fine-mapping algorithms 7,8 , designed with the goal to 65 resolve known genetic associations to smaller sets of variants, can be used with the high 66 density genomic data to further improve the precision of the genetic associations. 67
We therefore conducted an analysis of a large pool of spontaneous resolvers and 68 chronic patients of HCV using the Immunochip platform, the SNP2HLA algorithm with 69 the T1DGC MHC imputation reference panel 6 , and a recently-developed fine-mapping 70 algorithm 8,9 to (1) more precisely define the susceptible variant within the known 71 associated loci; and (2) identify additional loci associated with clearance. Similar 72 successes have been achieved in other diseases such as inflammatory bowel disease 8, 10 . 73
Additionally, we explored the hypothesis that there are shared mechanisms that define a 74 "brisk" immunity able to confer both susceptibility to autoimmune disease and improved 75 control of pathogens. We also examined the influence of region (North America versus 76
European) upon associations with HLA within the European ancestry, as previous studies 77 have shown variability of results, especially for the class I locus [11] [12] [13] [14] . 78
79

Results
80
The final dataset after QC has 166,537 variants for 527 cases/828 controls of European 81 ancestry; and 171,161 variants for 75 cases/171 controls of African ancestry (Table 1) . 82
For each ancestry, we performed logistic regression under the additive model using the 83 first two principal components as covariates. The QQ plot (Figure 1, using common 84 variants with >2% minor allele frequency) and the genomic control (GC) factors (0.98 for 85
the European ancestry and 0.92 for the African ancestry using designated null variants) 86 indicate the effective control of the population stratification. 87
For European samples, we identified 8 genome-wide significant variants (p-value < 88 5E-8) in two loci ( Figure 2 and Table 2 ). The variant on chromosome 19, rs8099917, 89
shows the strongest association with spontaneous clearance (p-value=5E-16). Patients 90 carrying the minor allele, G, are on average 2.5x (odds ratio=0.39) less likely to 91 spontaneously clear the virus compared to those with two copies of the C allele. This 92 variant is roughly 7,000 base pairs upstream of the IL28B gene, and has been previously 93 reported to be associated with HCV spontaneous clearance 4 and the response to chronic 94 HCV therapy in Asian populations 15 . Previous studies have also shown an association 95 between IL28B and interferon-based clearance of HCV 16 . Because the IL28B/IFLN4 96 region was not designed as a high-density locus in Immunochip, we could not test other 97 variants in this region for their association with HCV spontaneous clearance, and was 98 unable to provide a better resolution in this locus. 99
The other genome-wide significant locus for the European samples is the major 100 histocompatibility complex (MHC) locus. Genome-wide significant variants in this 101 region are reported in Table 2 (before imputation). We used SNP2HLA 6 and a 102 customized reference panel from a T1D study to impute missing variants, HLA alleles 103 and amino acid residues for this region. We identified 12 SNPs and 5 amino acids that are 104 genome-wide significant ( Figure 3 and Table 3 , boldfaced). No secondary signal in this 105 region exceeded the suggestive significance threshold (1x10 -5 ) after conditioning on the 106 primary signal. Therefore, all variants reported in Table 3 account for the same 107 association signal. Using a fine-mapping algorithm described in another study 9 , we 108 constructed the 99% credible set, which is a set of variants that has 99% probability of 109 having the causal variant in this locus (Table 3, full). Comparing with the previous study 4 110 which identified this association to a region of more than 1 mega base pairs, we mapped 111 this association to a much smaller region of 50,562 base pairs. 112
Neither the MHC nor the IL28B locus was genome-wide significant in the African 113 ancestry. Using the heterogeneity test (fixed-effect, implemented in the R metafor 114 package), we found that neither the MHC locus nor the IL28B locus have significantly 115 different effect size (p-values =0.47 and 0.29 respectively) across the two populations. 116 Therefore, the difference in the significance is likely driven by the sample size and/or the 117 allele frequency differences. 118
In addition to the genome-wide significant loci, we examined genes outside the HLA 119 that have been previously associated with HCV spontaneous clearance 17 . Only genes 120 IFNG-AS1 (p-value=6E-4) and STAT1 (p-value=3E-4) showed marginal evidence of 121 association (p-value < 1E-3), and this effect was observed only in the European cohort. 122
No genes reached the marginal p-value threshold in the samples of African ancestry. 123 IFNG-AS1 is a long noncoding RNA that is expressed in CD4 T cells and promotes Th1 124 responses 18 . STAT1 is one of the key mediators of the type I, II and III interferon 125
responses. 126
Since HCV is particularly diverse, with up to a 30% difference at the amino acid 127 level between major viral genotypes, the strain of infecting virus may influence HLA-128 mediated clearance 13 . Unfortunately, information regarding the virus genotype or subtype 129
was not available in this study, especially in those persons who already cleared the virus, 130 so a direct comparison is therefore not possible. However, an indirect comparison is 131 possible by taking advantage of the observation that North American patients are much 132 more likely to be infected with the 1a virus and European patients are much more likely 133 to be infected by the 1b virus{Pawlotsky:1995eg}. We observed that the association in 134 the class II MHC locus, after accounting for the sample size difference (Methods), is 135 stronger in North American samples than in European samples ( Figure 4 ) with marginal 136 significance (p=0.05), This suggests that viral subtype may have influenced the genetic 137 mechanism underlying the clearance of HCV. Meta-analysis by cohorts confirms this 138 observation ( Figure 5 ). We also interrogated the potentially protective effect of certain 139
SNPs associated with HLA class I alleles previously implicated in spontaneous clearance. (Table 4 ). We found no shared variant after considering multiple testing. This 151 analysis was only performed in the European cohort because the African cohort has 152 limited power due to the sample size, and GWAS results in samples of African ancestry 153 for other autoimmune disorders is more limited. A full exploration of the hypothesis that 154 susceptibility to autoimmunity also confers ability to clear HCV will require a larger 155 sample size. 156
An alternate approach, taken by the International Genetics of Ankylosing 157
Spondylitis Consortium 21 , is to search for the reported associations with other diseases in 158 loci having suggestive evidence (p-value < 1E-5), i.e., the MHC and the IL28B loci in 159 this study. We only performed the search in IL28B because MHC has been already 160 implicated in many autoimmune disorders. We searched within 0.5Mb around the lead 161 SNP (rs8099917) in IL28B for associations with other diseases that have been reported in 162 the NHGRI GWAS catalog (search performed through UCSC Table Browser We have conducted a genome-wide association study to identify genomic variants 171 underlying the HCV spontaneous clearance using immunochip. Consistent with previous 172 reports 4 , two loci were found to be significantly associated with the HCV spontaneous 173 clearance in the European cohort. The immunochip design, the imputation pipeline 174 specifically designed for the MHC region and the novel fine-mapping algorithm 175 facilitated the accurate characterization of classical HLA types and allowed us to achieve 176 a higher resolution in the MHC region. Twelve SNPs and 5 amino acids in the MHC 177 region were found to be significantly associated and no secondary signal remains after 178 conditioning on the best SNP. Fine-mapping mapped this association to a region of about 179 50 kilo base pairs, down from 1 mega base pairs in the previous study. We found no 180 associated variants in the African cohort, probably due to different genetic background 181 (in the case of the IL28B locus) and limited sample size (in the case of the MHC locus). 182
Additional analyses suggested that the association in the class II MHC locus might be 183 significantly stronger for virus subtype 1a than 1b, suggesting that viral subtype may 184 have influenced the genetic mechanism underlying the clearance of HCV 13,23 . Additional 185 evidence, such as virus typing, is needed to confirm this finding. 186
Limitations of this study include inability to dissect SNPs near the IL28B/IFLN4 187 region, as this loci had not been previously implicated in autoimmune GWAS studies. 188
While the Immunochip did include rs8099917 as a surrogate for this region, additional 189 information regarding associations with rs12979860 and ss469415590 is not 190 available{Kumar:2016ea}. Also, this study was a fine-mapping exercise that narrowed 191 the MHC significantly but was not fully independent due to considerable overlap with the 192 previous GWAS. 193
Previous studies of GWAS data revealed that there are SNPs and loci with evidence 194 of association across multiple immune-mediated diseases 19 . We found several variants 195 that have suggestive and plausible evidence of associations with both HCV spontaneous 196 clearance and another autoimmune disorders. Despite the observation that none of these 197 variants are significant after the strict Bonferroni correction, they jointly confirm the 198 concept that shared genetic mechanisms underlie autoimmune disorders and suggest the 199 hypothesis that susceptibility to autoimmunity may also confer ability to clear HCV. Mangia and colleagues, UK Drug Use Cohort) were genotyped in this study, as 208 previously described 4 . Self-clearance of HCV was coded as cases (718 samples) and 209 persistence of HCV was coded as controls (1,180 samples). Samples with unidentified 210 clearance status were not used (46 samples). All samples were genotyped using 211
Illumina's Immunochip, a custom Infinium chip with 196,524 SNPs and small in/dels. A 212 large number of these variants are in 187 high-density regions known to be associated 213 with twelve autoimmune disorders and inflammatory diseases. Variants in these high-214
density regions include 289 established associations, variants from 1000 genome project 215 low coverage pilot 1 study 24 , and variants discovered in re-sequencing 25 . In addition, 216 roughly 25,000 variants were included as replication of unrelated diseases as part of the 217 WTCCC2 project, with the purpose of serving as null SNPs in analyses. 218
Sample ethnicities 219
To identify the sample ethnicities, we first constructed the principal component axes 220 Variants that failed the Hardy-Weinberg equilibrium test in controls (p-value ≤ 1E-5) or 233 had low call rate (≤95%) were identified, and 24,820 variants were removed in European 234 samples and 20,196 variants were removed in African samples. The remaining variants 235 were used to perform QC in samples. Samples were cleaned for having low call rate 236 (≤95%) or having high heterozygosity rate (> 3 standard deviations from the mean). 237
We then created a LD pruned dataset for calculating the identity by state (IBS) 238 matrix and the principal components. We pruned the variants using a sliding window of 239 50 variants, step size of 5 variants and variance inflation factor threshold of 1.25. There 240 were 20,782 variants in European samples, and 21,778 variants in African samples after 241 the pruning. The IBS matrix was calculated using this LD pruned dataset and checked for 242 sample relatedness. 28 duplicated samples in European cohorts and 9 duplicated samples 243 in cohorts of African ancestry have been identified and removed (pi_hat>0.9). The final 244 dataset has 527 cases and 828 controls for European cohorts, and 75 cases and 171 245 controls for African cohorts. 246
To correct for within European and within African population stratification, we 247 calculated the principal components for samples of European ancestry and African 248 ancestry, respectively. The first two principal components sufficiently control the 249 population stratification in both ancestries (results not shown) and were use in the 250 association analysis as covariates. 251
Imputation 252
Imputation of the MHC region was performed on QC cleaned data using SNP2HLA 6 . 
Association test 261
All association tests were performed in PLINK 1.07 27 using the logistic regression. We 262 assumed additive models and used the first two principal components as covariates in the 263 regression. HCV spontaneous clearance was coded as case so an odds ratio > 1 indicates 264 the tested allele increases the probability of spontaneous clearance. 265
Test whether an association has the same effect size across two cohorts 266
For a cohort of sample size N, assume the association of interest has p-value of p, and the 267 chi-square statistic, calculated from p using the chi-square distribution, is c 2 . If this 268 association has the same effect size in the other cohort, the expected chi-square statistic Data availability: The data that support the findings of this study are available from the 290 corresponding authors but restrictions apply to the availability of these data, which were 291 used under license for the current study, and so are not publicly available. Data are 292 however available from the authors upon reasonable request. 293
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